Form 4: TD SYNNEX Executive Sells Shares Via 10b5-1 Plan
Insider Transaction Report
TD SYNNEX Director and Hyve Solutions Executive Dennis Polk sold 2,853 shares of common stock on January 5, 2026, through a pre-arranged 10b5-1 trading plan.
Summary
- Dennis Polk, a Director and Hyve Solutions Executive at TD SYNNEX CORP (SNX), sold a total of 2,853 shares of common stock.
- The sales occurred on January 5, 2026, and were executed under a Rule 10b5-1 trading plan adopted on October 13, 2024.
- The shares were sold at weighted average prices ranging from $152.76 to $156.79 per share.
- Following these transactions, Polk beneficially owns 72,807 shares indirectly through a trust and 34,099 shares directly.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While it's an insider sale, it was pre-scheduled under a 10b5-1 plan, which mitigates concerns about its implications for the company's immediate prospects. It's a routine personal financial management action.
Positives
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned, non-discretionary transaction rather than an immediate reaction to new information.
Negatives
- Insider selling, even under a 10b5-1 plan, reduces the executive's direct equity stake in the company.
Future Outlook
N/A
Industry Context
This transaction is an individual executive's planned sale and does not inherently reflect broader industry trends or competitive positioning for TD SYNNEX. Such sales are common for executives managing personal portfolios.
Related Party Transactions
- The sales were made on behalf of the Polk family trust, of which Dennis Polk is a trustee, constituting a related party transaction.
Stakeholder Impact
- Shareholders may view the insider sale as a slight negative, though the 10b5-1 plan mitigates concerns. The overall impact on employees, customers, suppliers, and creditors is negligible as this is a personal financial transaction by an executive.
Key Dates
| Date | Description |
|---|---|
| 2024-10-13 | Date Rule 10b5-1 trading plan was adopted by Dennis Polk. |
| 2026-01-05 | Date of common stock sales by Dennis Polk. |
| 2026-01-06 | Date the Form 4 was signed by Cheryl Grant, attorney-in-fact. |
Recommendation
holdThe insider sale by Dennis Polk, a Director and Executive, was executed under a pre-arranged 10b5-1 trading plan. This type of transaction is typically for personal financial planning and does not usually signal a change in the company's fundamental outlook or performance. Therefore, it does not warrant a change in investment recommendation based solely on this filing. Investors should continue to hold based on broader company fundamentals and market conditions.
Keywords
TD SYNNEX, SNX, Dennis Polk, Insider Sale, Form 4, 10b5-1 Plan, Equity Transaction, Director, Executive, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.